EW
US EQUITY
Health Care
Health Care Equipment
CIK: 1099800
Edwards Lifesciences (EW) Quant Factor Diagnostic & Fair Value Model
Edwards Lifesciences (Ticker: EW) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$89.07
-1.13%
Latest Close (2026-10-23)
Market Cap: $4.27B
P/E Ratio: 53.0
Momentum Strength
3M / 12M
+7.26%
1M: +3.90%
12M: +15.92%
Quality (ROE)
Point-in-Time
+9.02%
Trailing Return on Equity
Technical Trend
RSI 14
56.1
SMA50: $88.06
SMA200: $85.23
Valuation Multiplier
Trailing
53.0
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
EW trades at 53.0x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1099800 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-04 | $1.74B | $241.90M | $695.70M | $0.42 |
| 10-Q | 2025-12-31 | 2026-08-04 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-04 | $1.53B | $333.20M | $570.60M | $0.56 |
| 10-Q | 2026-03-31 | 2026-05-06 | $1.65B | $380.70M | $43.80M | $0.66 |
| 10-Q | 2025-03-31 | 2026-05-06 | $1.41B | $358.00M | $280.40M | $0.61 |
| 10-K | 2025-12-31 | 2026-02-25 | $6.07B | $1.07B | $1.60B | $1.83 |
| 10-K | 2024-12-31 | 2026-02-25 | $1.39B | $385.60M | $542.30M | $0.65 |
| 10-K | 2023-12-31 | 2026-02-25 | $1.27B | $369.90M | $895.80M | $0.61 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Edwards Lifesciences (EW) valuation multiples, momentum factors, and point-in-time filing conventions.
How should EW's current valuation multiple be interpreted? ↓
EW trades at a trailing P/E of 53.0x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are EW's key momentum and technical factor indicators? ↓
As of the latest close, EW shows a 1-month return of +3.90%, 3-month return of +7.26%, and 12-month return of +15.92%, with a 14-day RSI of 56.1. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for EW? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can EW be incorporated into systematic factor models? ↓
EW can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.